Wall Street Isn't Talking About High-Yield Medtronic Stock -- Here's Why It Should Be
Medtronic has a historically high 3% yield and is just two years away from becoming a Dividend King.
Medtronic (NYSE: MDT) is a large medical device manufacturer with a diverse portfolio, but it has recently undergone a transformation. Despite its reputation as a boring business, the company has managed to turn things around in a positive direction. Wall Street should pay closer attention to Medtronic for several reasons. Management has successfully steered the company away from bureaucratic issues and an overly complex business structure.
Additionally, Medtronic boasts an impressive 48-year streak of annual dividend increases, a feat that brings it closer to Dividend King status. This long history of consistent dividend growth might be enough to deter investors from focusing on other, more dynamic companies.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
